Healthcare Analysts discuss emerging therapies in chronic myeloid leukemia (CML), (relevant companies NVS, ENLV, TERN, TAK, BMY, PFE) on an ...
The US FDA has accepted the new drug application (NDA) for XS003, a formulation referencing the tyrosine kinase inhibitor (TKI) nilotinib (Tasigna), for treatment of chronic myeloid leukemia (CML). 1 ...
The FALCON Phase 2 trial is a U.S.-based, multicenter, randomized, double-blind, placebo-controlled trial evaluating the efficacy and safety of TERN-601, a novel oral GLP-1R agonist, with once-daily ...
A Michigan man facing possible deportation while dealing with life-threatening leukemia must be released from custody or at ...
Cervantes, a Michigan resident with leukemia, faces deportation but has been granted a bond hearing by a judge, challenging the Trump administration's policy. This ruling could allow ...
Study: Cannabidiol Alters Gene Expression Linked to Immune Response and Cell Death in Leukemia Cells
Researchers from the Stephan Angeloff Institute of Microbiology have published new findings in Global Medical Genetics ...
The Body Optimist on MSN
What this young woman thought was a simple dental hygiene problem was hiding something much worse.
Amber, 21, had recently noticed persistent bleeding gums and unexplained fatigue. This "harmless" symptom was actually a sign of serious leukemia, fortunately diagnosed in time. Misleading symptoms ...
Federal authorities refuse to release a Michigan man in a pending deportation case, despite his life-threatening leukemia and the inconsistent health care he's received while in custody since August, ...
Study results showed the odds of achieving a major molecular response were significantly higher with nilotinib compared with imatinib at 12 months. Nilotinib was associated with greater odds of a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback